Braxia Scientific Corp.
BRAX
CNSX
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -666.70K | -203.40K | -597.20K | -5.66M | -1.60M |
| Total Depreciation and Amortization | 54.30K | 54.70K | 41.80K | 119.80K | 139.90K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 30.00K | 26.60K | 11.90K | 4.03M | -120.70K |
| Change in Net Operating Assets | 191.00K | -3.50K | 122.80K | 539.70K | -1.13M |
| Cash from Operations | -391.40K | -125.60K | -420.70K | -974.00K | -2.71M |
| Capital Expenditure | -6.70K | 0.00 | -1.20K | -38.30K | -35.10K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | 0.00 | 0.00 |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | 20.10K | -10.10K | 24.70K | 73.70K |
| Cash from Investing | -6.70K | 20.10K | -11.20K | -13.60K | 38.50K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -42.50K | -7.90K | -14.20K | -9.00K | -6.30K |
| Issuance of Common Stock | -- | -- | -- | 1.26M | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -31.20K | -5.90K | -10.60K | 928.10K | -4.60K |
| Foreign Exchange rate Adjustments | 2.10K | -1.70K | -4.80K | 37.20K | -32.60K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -427.30K | -113.10K | -447.30K | -22.40K | -2.71M |
